These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6229495)

  • 21. Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties.
    Rios AM; Miller FR; Heppner GH
    Cancer Immunol Immunother; 1983; 15(2):87-91. PubMed ID: 6553517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
    Watson GA; Lopez DM
    J Immunol; 1995 Sep; 155(6):3124-34. PubMed ID: 7673727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
    Fung PY; Longenecker BM
    Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterically induced regulation of systemic immune responses. II. Suppression of proliferating T cells by an Lyt-1+, 2- T effector cell.
    Silverman GA; Peri BA; Fitch FW; Rothberg RM
    J Immunol; 1983 Dec; 131(6):2656-61. PubMed ID: 6196395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lyt-2+ suppressor T cells are resistant to anti-Lyt-2 antibody blocking.
    Hollander N
    J Immunol; 1985 Apr; 134(4):2205-8. PubMed ID: 2579133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor.
    Mokyr MB; Barker E; Weiskirch LM; Takesue BY; Pyle JM
    Cancer Res; 1989 Aug; 49(16):4597-606. PubMed ID: 2568174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.
    Bonaventure J; Nigam VN; Brailovsky CA
    Cancer Immunol Immunother; 1985; 20(2):167-74. PubMed ID: 3849979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions.
    Stanton TH; Calkins CE; Jandinski J; Schendel DJ; Stutman O; Cantor H; Boyse EA
    J Exp Med; 1978 Oct; 148(4):963-73. PubMed ID: 702065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flip-flop in the Lyt 2 phenotype of T cells from radiation chimaeras between Thy 1 congenic donor and recipient mice.
    Thomas DB; Keeler KD
    Immunology; 1984 Mar; 51(3):563-70. PubMed ID: 6141996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor.
    Varesio L; Giovarelli M; Landolfo S; Forni G
    Cancer Res; 1979 Dec; 39(12):4983-8. PubMed ID: 159126
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection and characterization of cytotoxic T lymphocyte precursors in the murine intestinal intraepithelial leukocyte population.
    Ernst PB; Clark DA; Rosenthal KL; Befus AD; Bienenstock J
    J Immunol; 1986 Mar; 136(6):2121-6. PubMed ID: 2936822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of large granular T lymphocytes in vivo during viral infection.
    Biron CA; Natuk RJ; Welsh RM
    J Immunol; 1986 Mar; 136(6):2280-6. PubMed ID: 3485144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
    Awwad M; North RJ
    J Exp Med; 1988 Dec; 168(6):2193-206. PubMed ID: 2974065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical influence on murine immunity and tumor growth: relationship of body temperature and hormones with splenocytes.
    Ratajczak HV; Lange RW; Sothern RB; Hagen KL; Vescei P; Wu J; Halberg F; Thomas PT
    Proc Soc Exp Biol Med; 1992 Apr; 199(4):432-40. PubMed ID: 1532258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of suppressor T-cells induced with concanavalin A in vivo by cell electrophoresis.
    Shimizu M; Nakamura M; Kataoka T; Iwaguchi T
    J Pharmacobiodyn; 1988 Mar; 11(3):152-7. PubMed ID: 2970536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.